News
Company News Press Release Announcements |
On September 10, Shanghai Denovo PharmaceuticalTechnology Co., Ltd., a subsidiary of Qingfeng Pharmaceutical Group, held aTLR8 agonist DN1508052-01 Phase I clinical trial kick-off meeting at Shangh...
2020-09-17
On August 25, 2020, our clinical research team held a GP681 clinical study kick-off meeting in Shanghai Xuhui District Central Hospital, marking that our innovative drug GP681 has officially ...
2020-09-17
On August 30th, the high-profile "2019 China Pharmaceutical Industry Top 100 List" was grandly released in Zhuhai. Qingfeng Pharmaceutical Group was once again nominated as the 64th place among ...
2020-09-09
The Class 4 chemical generic Sorafenib tosylate tablets (trade name: Ligesitai®) developed by Jiangxi Shanxiang Pharmaceutical Co., Ltd., a subsidiary of Qingfeng Pharmaceutical Group, were ...
2020-08-11
On July 8, Bangkaxin® (Esomeprazole Magnesium Enteric-coated Tablets) declared by Qingfeng Pharmaceutical Group and Jiangxi Shanxiang Pharmaceutical Co., Ltd. was approved by NMPA. The successful ...
2020-07-08
07/23
2020
The first generic of Esomeprazole Magnesium Enteric-coated Tablets was approved for marketing, which is deemed to pass consistency evaluation. A few days ago, Esomeprazole Magnesium Enteric-coated ...
05/19
2020
Recently, Jiangxi Qingfeng Pharmaceutical'sapplication for Apixaban tablets (acceptance number CYHS1800008) submittedunder the generic category 4 was approved, and the approval number was H20203204...
05/23
2018
China Jiangxi Net News On May 21, the reporter learned from the Jiangxi Food and Drug Administration that the two formulations of Entecavir (trade name: Weiliqing) dispersible tablets and capsules...
05/09
2017
On April 7th, at the Qingfeng Pharmaceutical Valley Hangzhou Investment Promotion Conference held in Ganzhou City, Qingfeng Pharmaceutical Group and Zhejiang University signed a cooperation agreeme...
12/22
2016
From January to September this year, the main business income exceeded 2.7 billion CNY, and the tax revenue exceeded 500 million CNY. In the past five years, the annual average investment of 150...
04/24
2019
To ensure the safety of enterprises, society and people’s lives and property, prevent the occurrence of sudden environmental pollution accidents, and quickly and effectively control and deal with ...
07/02
2018
According to the "Guidelines for Accounting Methods and Reporting of Greenhouse Gas Emissions by Enterprises in Other Industries (for Trial Implementation)" issued by the National Development and ...
|
|
Qingfeng Pharmaceutical Group Co.Ltd
Location：8 Zhandong Av., Zhanggong, Ganzhou, Jiangxi Province, China
Phone：+86-0797-5560800,5560600
Fax: +86-0797-5560620